About the book
Demyelination disorders compose a substantial part of the spectrum of the neurological morbidity. Apart from the Multiple Sclerosis, which is a common medical problem, affecting a large number of people in the most precious, productive and creative period of the life, a substantial number of other demyelinating conditions impose a heavy burden on the life of the patients, causing an impressive decline of the quality of life.
This book may lead to a new insight into etio-pathogenetic mechanisms of the demyelinating diseases in correlation with the neuropathological alterations and the clinical manifestation of the most frequent ones. In addition the epidemiological analysis, the detection of the risk factors and the genetic investigation may provide new data for a further understanding of the heterogeneity of the disorders and the ways of the proper therapeutic approaching. The detailed clinical investigation may lead to a diagnostic accuracy, which would be important for the prompt therapeutic confrontation of the patients, improving their quality of life. In addition experimental research in the field of demyelination disorders is going to open new horizons in the cellular and neurochemical interactions in the CNS underlining the validity of the remyelinating processes for the structural and functional homeostatic equilibrium of the CNS.